BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35103340)

  • 1. Approaches to minimize the effects of P-glycoprotein in drug transport: A review.
    Husain A; Makadia V; Valicherla GR; Riyazuddin M; Gayen JR
    Drug Dev Res; 2022 Jun; 83(4):825-841. PubMed ID: 35103340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistance.
    Kwatra D; Vadlapatla RK; Vadlapudi AD; Pal D; Mitra AK
    Int J Pharm; 2010 Aug; 395(1-2):114-21. PubMed ID: 20573570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptide prodrug approach to evade efflux pumps and CYP3A4 metabolism of lopinavir.
    Patel M; Sheng Y; Mandava NK; Pal D; Mitra AK
    Int J Pharm; 2014 Dec; 476(1-2):99-107. PubMed ID: 25261710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice.
    Marchetti S; de Vries NA; Buckle T; Bolijn MJ; van Eijndhoven MA; Beijnen JH; Mazzanti R; van Tellingen O; Schellens JH
    Mol Cancer Ther; 2008 Aug; 7(8):2280-7. PubMed ID: 18723475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
    Lee TD; Lee OW; Brimacombe KR; Chen L; Guha R; Lusvarghi S; Tebase BG; Klumpp-Thomas C; Robey RW; Ambudkar SV; Shen M; Gottesman MM; Hall MD
    Mol Pharmacol; 2019 Nov; 96(5):629-640. PubMed ID: 31515284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Minireview: Usefulness of Transporter-Targeted Prodrugs in Enhancing Membrane Permeability.
    Murakami T
    J Pharm Sci; 2016 Sep; 105(9):2515-2526. PubMed ID: 27321236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational analysis of human ATP-binding cassette transporter ABCB1 in lipid nanodiscs and inhibition by the antibodies MRK16 and UIC2.
    Ritchie TK; Kwon H; Atkins WM
    J Biol Chem; 2011 Nov; 286(45):39489-96. PubMed ID: 21937435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
    Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated efflux with m-TOR inhibitors.
    Minocha M; Khurana V; Qin B; Pal D; Mitra AK
    Int J Pharm; 2012 Sep; 434(1-2):306-14. PubMed ID: 22633931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of P-gp and MRP2 on cellular translocation of gemifloxacin.
    Vadlapatla RK; Vadlapudi AD; Kwatra D; Pal D; Mitra AK
    Int J Pharm; 2011 Nov; 420(1):26-33. PubMed ID: 21864659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening novel CNS drug candidates for P-glycoprotein interactions using the cell line iP-gp: In vitro efflux ratios from iP-gp and MDCK-MDR1 monolayers compared to brain distribution data from mice.
    Ozgür B; Saaby L; Janfelt C; Langthaler K; Eneberg E; Jacobsen AM; Badolo L; Montanari D; Brodin B
    Eur J Pharm Biopharm; 2021 Dec; 169():211-219. PubMed ID: 34756975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical interaction of anti-HCV telaprevir with the ABC transporters P-glycoprotein and breast cancer resistance protein.
    Fujita Y; Noguchi K; Suzuki T; Katayama K; Sugimoto Y
    BMC Res Notes; 2013 Nov; 6():445. PubMed ID: 24196382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-formulation of P-glycoprotein Substrate and Inhibitor in Nanocarriers: An Emerging Strategy for Cancer Chemotherapy.
    Saneja A; Dubey RD; Alam N; Khare V; Gupta PN
    Curr Cancer Drug Targets; 2014; 14(5):419-33. PubMed ID: 24720364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of multidrug resistance-linked P-glycoprotein (ABCB1) function by 5'-fluorosulfonylbenzoyl 5'-adenosine: evidence for an ATP analogue that interacts with both drug-substrate-and nucleotide-binding sites.
    Ohnuma S; Chufan E; Nandigama K; Jenkins LM; Durell SR; Appella E; Sauna ZE; Ambudkar SV
    Biochemistry; 2011 May; 50(18):3724-35. PubMed ID: 21452853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel application of rhein and its prodrug diacerein for reversing cancer-related multidrug resistance through the dual inhibition of P-glycoprotein efflux and STAT3-mediated P-glycoprotein expression.
    Teng YN; Kao MC; Huang SY; Wu TS; Lee TE; Kuo CY; Hung CC
    Biomed Pharmacother; 2022 Jun; 150():112995. PubMed ID: 35658243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-ionic Surfactants as a P-Glycoprotein(P-gp) Efflux Inhibitor for Optimal Drug Delivery-A Concise Outlook.
    Rathod S; Desai H; Patil R; Sarolia J
    AAPS PharmSciTech; 2022 Jan; 23(1):55. PubMed ID: 35043278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of expression/function of intestinal P-glycoprotein under disease states.
    Murakami T; Bodor E; Bodor N
    Expert Opin Drug Metab Toxicol; 2020 Jan; 16(1):59-78. PubMed ID: 31821048
    [No Abstract]   [Full Text] [Related]  

  • 19. Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.
    Shukla S; Robey RW; Bates SE; Ambudkar SV
    Drug Metab Dispos; 2009 Feb; 37(2):359-65. PubMed ID: 18971320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp).
    Zhang H; Xu H; Ashby CR; Assaraf YG; Chen ZS; Liu HM
    Med Res Rev; 2021 Jan; 41(1):525-555. PubMed ID: 33047304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.